AssureRx Announces New Round of Funding.

AssureRx, a personalized medicine company, today announced that it has closed a round of funding. The company was founded in 2006 to license and commercialize pharmacogenetic technology from Cincinnati Children’s Hospital Medical Center and Mayo Clinic. The technology utilized in the AssureRx non-invasive, pharmacogenetic test measures, analyzes and interprets the genes of patients with common neuro-psychiatric disorders to predict which drugs are best choices for each specific patient. The test helps to take much of the guesswork out of prescribing medications.

Click here to download full story